NPPA issued a notification regarding fixation of the retail price of Bilastine IP 40 mg + Montelukast Sodium IP eq. to Montelukast 10 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Aristo Pharmaceuticals Pvt Ltd. (Marketer)

Apr 30, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on April 27, 2026, issued a notification regarding fixation of the retail price of Bilastine IP 40 mg + Montelukast Sodium IP eq. to Montelukast 10 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Aristo Pharmaceuticals Pvt Ltd. (Marketer).

The following has been stated: -

•For each Film-coated tablet containing Bilastine IP 40 mg + Montelukast Sodium IP eq. to Montelukast 10 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Aristo Pharmaceuticals Pvt Ltd. (Marketer) the retail price is 21.22 (Rs).

[Notification No.: 19(5104)/2026/DP/NPPA/Div.III/13701/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT